Bayer AG (FRA:BAYN) received a €118.00 ($131.11) target price from stock analysts at equinet AG in a research report issued on Wednesday. The firm currently has a a “buy” rating on the stock.

A number of other research analysts have also weighed in on the company. Bankhaus Lampe set a €103.00 ($114.44) price objective on Bayer AG and gave the company a “buy” rating in a report on Wednesday. Goldman Sachs Group Inc. set a €129.00 ($143.33) price objective on Bayer AG and gave the company a “buy” rating in a report on Wednesday. JPMorgan Chase & Co. restated a “neutral” rating on shares of Bayer AG in a report on Wednesday. Commerzbank AG set a €110.00 ($122.22) price objective on Bayer AG and gave the company a “buy” rating in a report on Wednesday. Finally, Nord/LB set a €112.00 ($124.44) price objective on Bayer AG and gave the company a “buy” rating in a report on Wednesday. Two analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of €112.17 ($124.63).

Analyst Recommendations for Bayer AG (FRA:BAYN)

Shares of Bayer AG (FRA:BAYN) opened at 92.20 on Wednesday. The company has a 50-day moving average of €95.29 and a 200-day moving average of €95.82. The stock has a market capitalization of €76.24 billion and a price-to-earnings ratio of 16.93. Bayer AG has a 1-year low of €83.87 and a 1-year high of €127.21.

Bayer AG Company Profile

.

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.